Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4 , Pages 343-347 , Winter 2005

Gene Therapy for Heart Failure

  • Lina Nayak
  • ,
  • Todd K. Rosengart, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Todd K. Rosengart, MD, 2650 Ridge Avenue, Burch 100, Evanston, IL 60201.

References 

  1. Most P , Eicher C , Volkers M , et al.   Hope for a broken heart? . Trends Biotechnol . 2004;22:487–489
  2. Hoshijima M . Gene therapy targeted at calcium handling as an approach to the treatment of heart failure . Pharmacol Ther . 2005;105:211–228
  3. Califf RM , Adams KF , McKenna WJ , et al.   A randomized controlled trial of epoprostenol therapy for severe congestive heart failure (the flolan international randomized survival trial (FIRST)) . Am Heart J . 1997;134:44–54
  4. Packer M , Coats AJ , Fowler MB , et al.   Effect of carvedilol on survival in severe chronic heart failure . N Engl J Med . 2001;344:1651–1658
  5. McKelvie RS , Yusuf S , Pericak D , et al.  RESOLVD pilot study investigators   Comparison of candesartan, enalapril, and their combination in congestive heart failure (randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study) . Circulation . 1999;100:1056–1064
  6. CIBIS-II Investigators and Committees . The cardiac insufficiency bisoprolol study II (CIBIS-II). A randomised trial . Lancet . 1999;353:9–13
  7. Abraham WT , Fisher WG , Smith AL , et al.   Cardiac resynchronization in chronic heart failure . N Engl J Med . 2002;346:1845–1853
  8. Rose EA , Gelijns AC , Moskowitz AJ , et al.   Long-term mechanical left ventricular assistance for end-stage heart failure . N Engl J Med . 2001;345:1435–1443
  9. Hosenpud JD , Bennett LE , Keck BM , et al.   The registry of the international society for heart and lung transplantation (eighteenth official report-2001) . J Heart Lung Transplant . 2001;20:805–815
  10. Poller W , Fechner H , Kurreck J , et al.   Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. approaches and perspectives . Z Kardiol . 2004;93:171–193
  11. Suzuki Y , Nakano K , Sugiyama M , et al.   betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction . J Cardiovasc Pharmacol . 2004;44:329–334
  12. Bristow MR . Why does the myocardium fail? Insights from basic science . Lancet . 1998;352(suppl 1):SI8–SI14
  13. RockmanHA, Koch WJ, Lefkowitz RJ: Seven-transmembrane-spanning receptors and heart function. Nature 415:206212, 200.
  14. Drazner MH , Peppel KC , Dyer S , et al.   Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes . J Clin Invest . 1997;99:288–296
  15. Rockman HA , Chien KR , Choi DJ , et al.   Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice . Proc Natl Acad Sci USA . 1998;95:7000–7005
  16. Freeman K , Lerman I , Kranias EG , et al.   Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy . J Clin Invest . 2001;107:967–974
  17. Tevaearai HT , Eckhart AD , Shotwell KF , et al.   Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor . Circulation . 2001;104:2069–2074
  18. White DC , Hata JA , Shah AS , et al.   Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction . Proc Natl Acad Sci USA . 2000;97:5428–5433
  19. Shah AS , White DC , Emani S , et al.   In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction . Circulation . 2001;103:1311–1316
  20. Williams ML , Hata JA , Schroder J , et al.   Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts . Circulation . 2004;109:1590–1593
  21. Lai NC , Roth DM , Gao MH , et al.   Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure . Circulation . 2004;110:330–336
  22. Feldman AM . Adenylyl cyclase (a new target for heart failure therapeutics) . Circulation . 2002;105:1876–1878
  23. Post SR , Hammond HK , Insel PA . Beta-adrenergic receptors and receptor signaling in heart failure . Annu Rev Pharmacol Toxicol . 1999;39:343–360
  24. Post SR , Hilal-Dandan R , Urasawa K , et al.   Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes . Biochem J . 1995;311(Pt. 1):75–80
  25. Roth DM , Gao MH , Lai NC , et al.   Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy . Circulation . 1999;99:3099–3102
  26. Roth DM , Bayat H , Drumm JD , et al.   Adenylyl cyclase increases survival in cardiomyopathy . Circulation . 2002;105:1989–1994
  27. Roth DM , Lai NC , Gao MH , et al.   Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice . Am J Physiol Heart Circ Physiol . 2004;287:H172–H177
  28. Lai NC , Roth DM , Gao MH , et al.   Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity . Circulation . 2000;102:2396–2401
  29. Tomaselli GF , Marban E . Electrophysiological remodeling in hypertrophy and heart failure . Cardiovasc Res . 1999;42:270–283
  30. Hasenfuss G , Pieske B . Calcium cycling in congestive heart failure . J Mol Cell Cardiol . 2002;34:951–969
  31. del Monte F , Hajjar RJ . Targeting calcium cycling proteins in heart failure through gene transfer . J Physiol . 2003;546:49–61
  32. Miyamoto MI , del Monte F , Schmidt U , et al.   Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure . Proc Natl Acad Sci USA . 2000;97:793–798
  33. del Monte F , Williams E , Lebeche D , et al.   Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum ca(2+)-ATPase in a rat model of heart failure . Circulation . 2001;104:1424–1429
  34. Schmidt U , del Monte F , Miyamoto MI , et al.   Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum ca(2+)-ATPase . Circulation . 2000;101:790–796
  35. Hirsch JC , Borton AR , Albayya FP , et al.   Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction . Am J Physiol Heart Circ Physiol . 2004;286:H2314–H2321
  36. O’Donnell JM , Sumbilla CM , Ma H , et al.   Tight control of exogenous SERCA expression is required to obtain acceleration of calcium transients with minimal cytotoxic effects in cardiac myocytes . Circ Res . 2001;88:415–421
  37. Tada M , Toyofuku T . Molecular regulation of phospholamban function and expression . Trends Cardiovasc Med . 1998;8:330–340
  38. Hoshijima M , Ikeda Y , Iwanaga Y , et al.   Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery . Nat Med . 2002;8:864–871
  39. Iwanaga Y , Hoshijima M , Gu Y , et al.   Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats . J Clin Invest . 2004;113:727–736
  40. MacLennan DH , Kimura Y , Toyofuku T . Sites of regulatory interaction between calcium ATPases and phospholamban . Ann NY Acad Sci . 1998;853:31–42
  41. He H , Meyer M , Martin JL , et al.   Effects of mutant and antisense RNA of phospholamban on SR ca(2+)-ATPase activity and cardiac myocyte contractility . Circulation . 1999;100:974–980
  42. Eizema K , Fechner H , Bezstarosti K , et al.   Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction (comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter) . Circulation . 2000;101:2193–2199
  43. del Monte F , Harding SE , Dec GW , et al.   Targeting phospholamban by gene transfer in human heart failure . Circulation . 2002;105:904–907
  44. Meyer M , Belke DD , Trost SU , et al.   A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation . FASEB J . 2004;18:1312–1314
  45. Hoshijima M . Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies . Ann NY Acad Sci . 2004;1015:320–331
  46. Wahr PA , Michele DE , Metzger JM . Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes . Proc Natl Acad Sci USA . 1999;96:11982–11985
  47. Szatkowski ML , Westfall MV , Gomez CA , et al.   In vivo acceleration of heart relaxation performance by parvalbumin gene delivery . J Clin Invest . 2001;107:191–198
  48. Huq F , Lebeche D , Iyer V , et al.   Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes . Circulation . 2004;109:2780–2785
  49. Remppis A , Greten T , Schafer BW , et al.   Altered expression of the ca(2+)-binding protein S100A1 in human cardiomyopathy . Biochim Biophys Acta . 1996;1313:253–257
  50. Most P , Pleger ST , Volkers M , et al.   Cardiac adenoviral S100A1 gene delivery rescues failing myocardium . J Clin Invest . 2004;114:1550–1563
  51. Giordano FJ , Ping P , McKirnan MD , et al.   Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart . Nat Med . 1996;2:534–539
  52. Kay MA , Manno CS , Ragni MV , et al.   Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector . Nat Genet . 2000;24:257–261
  53. Feldman AM , McTiernan C . New insight into the role of enhanced adrenergic receptor-effector coupling in the heart . Circulation . 1999;100:579–582

PII: S1043-0679(05)00072-9

doi: 10.1053/j.semtcvs.2005.09.002

Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4 , Pages 343-347 , Winter 2005